Pages

Wednesday, August 29

After Half-Term Ponderings

After a flat first half, there’s not a vast amount to analyze with regards to the portfolio’s performance.  As such, this year’s half-term ponderings will focus on some (half-formed?) thoughts that have been germinating in my mind. 

- More QE – everywhere?
While the summer has largely been very quiet, the one thing that stands out is the increased likelihood of more quantitative easing or stimulus across the globe.  We’ve had the continual hints of QE3 from various Fed doves, and the market remembers Bernanke’s 2010 words at Jackson Hole that signaled QE2 while it waits for him to speak at the same venue on Friday (my guess is he’ll talk the market up, but we won’t see QE3 enacted till December’s Fed meeting).  More surprising was ECB President Mario Draghi’s July promise to “do whatever it takes” and claims that this action “will be enough”.  This being Europe, it goes without saying that “whatever it takes” depends on what country you’re from and the political dance matters as much as the promises; we wait to see what the reality of Draghi’s promise is and whether it’s enough.  Finally, there’s China where the data continues to come in weak, which has led to hopes of another 2009-style round of investment spending and stimulus.

Frankly, the fact we’re now discussing yet another round of QE should be sign to the Fed that they’re pushing on a string and that the previous rounds have failed at stimulating any sustainable growth.  However, I’m sure they feel the need to do something and the world of the counter-factual (“imagine how much worse it would be without QE1/2/Operation Twist/etc”) that they inhabit no doubt provides reason enough to try more unorthodox policy in the hope something works.   It’s no surprise that I’m skeptical about there being any medium-term benefits (despite the long-term costs).  However, with global QE/stimulus seemingly coming and the portfolio not particularly well positioned for it, Our Man’s added a little Gold as a 6-12month ‘trade’. 

- Has the Fed succeeded, at least on one psychological level, by turning everything into a yield asset?
While there’s much debate over the whether QE1/2/Lite, Operation Twist, et al have succeeded in generating any sustainable economic growth, they have succeeded in getting investors to focus on yields.  This is evident across markets, from the obvious places such performance of Investment Grade bonds (LQD: +9% YTD) and High Yield (JNK: +7.5%) to the keen focus on dividend yield stocks and on potential rental yields in the housing market.  By persuading investors to reach for yield, and kindling their animal spirits the Fed’s moves can be seen, so far, as a success by helping to drive a range of asset prices higher and endowing people with the wealth effect.

The problem, of course, is that by encouraging investors to “reach for yield” the Fed is also trying to persuade them to focus on return on capital rather than return of capital, and thus take more risk.  What do I mean by this?  Let’s take the simple examples: much has been written about how “cheap” stocks are, either due to their earnings yield (inverse of P/E) or their dividend yield.  As these yields compare very favourably to the low yield on a 10-year Treasury, the argument goes that one should own stocks.  After all, a 10-year Treasury yields a mere 1.6%, why wouldn’t you want to own the S&P 500, which has a 2.1% Dividend Yield, instead.  The answer of course lies in the risk you’re taking to earn those yields, or more simply – bond math matters.  In bond-world, a major risk metric is duration which simply tells you the weighted average of the time that the cash-flows from an asset are received.  For a 10-year Treasury bond this figure is between 7-8years, for the S&P based on the dividend yield it is 30-40years, hence in the world of bond-math you’re taking 4-5x the risk to own the S&P.  Suddenly, that extra 50bps/year of extra yield doesn’t quite look as attractive… 

- Earnings: But what about the margins?
Our Man has long been surprised at the resilience of corporate profit margins, which have hovered around historic highs for the l2mos and whose strong bounce-back from 2008/9 has driven Earnings-growth and been an important contributor to the rally in stocks.  Interestingly, we’re now starting to see Earnings-growth falter for the first time post-2008, with YOY Earnings growth turning negative in Q2-2012. 

This fall has also started to impact analyst projections for the upcoming quarters, which have steadily fallen throughout the year. 

Given the falling Earnings, and with margins at historic highs, it means that the market is relying on either multiple expansion or the quick reversion of this trend to help it go higher.  That should sound a note of caution to investors.

- Ideas: what’s Our Man looking at?
As is traditional a little note/insight, albeit brief this time, into some of the new things that Our Man is pondering and spending his free time looking at.
a). Europe:  There are signs, like this Global Shiller/CAPE analysis by Mebane Faber, that Europe is approaching the boundary being potentially very cheap.  While a number of European countries certainly look cheap comparative to other OECD nations, Our Man is keen on looking at them versus their own history before declaring them absolutely cheap and looking to invest.  Given Our Man is limited to US-listed positions, any future positions will largely be ETFs or potentially some ADRs.
b). Possible Puts/Shorts:  Generally, Our Man can only short using puts and predominantly has to use ETFs to get his exposure.  That said, I’m looking at few things that might be interesting.  The fall into two main buckets; (i) Stocks which have benefited as investors chased yield and may offer opportunity if the dividend isn’t as secure as it seems on the surface (areas of interest include REITs and some Consumer Staples/Telecoms), (ii) stocks where the drivers of growth are misunderstood or where the forward-looking expectations are particularly unrealistic (the two names, in particular, that have drawn Our Man’s interest are Lulu Lemon and Tesla, although Apple is, or rather one-day could be, potentially particularly fascinating)

Sunday, August 5

July 2012 Review

Portfolio Update
- There were no changes to the portfolio during the course of July.

Performance Review
July was a decent month for the portfolio, which rose 80bps putting the YTD performance back into the positive (+0.8%) though this pales in comparison to equity indices globally (S&P 500 TR: +11.0%, MSCI World +7.7%).

Continued concerns about the macro conditions in the US helped the Treasury Bond (+19bps) and Bond/Absolute Return (+15bps) buckets perform solidly.  This was compounded by the continued struggles of Mediterranean Europe, which saw the Currencies book (+34bps) add to performance as the Euro weakened.  This uncertainty was met with increased belief that monetary authorities across the world (especially Europe, US and China) were willing to engage in further QE (or fiscal stimulus in China’s case) and the resultant rally saw the aforementioned books give back much of their gains before month-end, and also hurt the China-related (-15bps) and Puts/Hedges (-9bps) positions.

The performance of the Equity-related books was quite mixed.  In the Value Equity book (+69bps), Dragonwave (DRWI) continued to negatively impact performance; while the company completed its business transforming acquisition of Nokia Siemens Network’s Microwave Trasportation business, the short-term prospects continue to reflect difficulties with the company issuing revenue guidance beneath analysts estimates for next quarter.  This negative performance was offset by another strong month from Theravance (THRX) – the company’s results were in-line with expectations, and the progress of their key drugs continues to be positive.   The Energy Efficiency book (-32bps) was a negative contributor, as analysts worried about the strength of XIDE’s earnings given the weakness in Europe and their sizeable business there.  The NCAV book (-2bps) is a solitary position at this time, and had limited impact on the portfolio.

Portfolio (as at 7/31 - all delta and leverage adjusted, as appropriate)
18.9% - Bond/Absolute Return Funds (DLTNX and HSTRX)
7.1% - Value Idea Equities (THRX, and DRWI)
5.2% - Treasury Bonds (TLT)
2.4% - Energy Efficiency (AXPW, and XIDE)
0.5% - NCAV Equities
0.0% - Other Equities (none)

-2.1% - China-Related Thesis (44bps premium in EWZ Jan-13 puts)
-0.4% - Hedges/Put Options (16bps in IWM Jan-13 puts, 12bps in SPY Jan-13 puts and 11bps XLY Jan-13 puts)

-12.9% - Currencies (EUO – Short Euro)

58.6% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.

Wednesday, July 4

June 2012 Review

Portfolio Update
- June saw the second (much smaller) tranche of the redemption discussed in April, with Our Man again deciding to reduce the cash position slightly and concentrate the exposure into the existing portfolio.

Performance Review
The markets bobbed around without any clear and consistent trend for the vast majority of the month before rallying strongly in the final days, after the latest European summit seemed to suggest another plan to ‘fix’ things.  The month was a different one for the portfolio, which various elements moving in different directions as some idiosyncratic company-related events largely made up for the broad under-performance of the more macro-related elements.  The end result however was rather flat performance (+0.07% in June), which pretty much summed up the first-half of the year (-0.01% YTD)

Unsurprisingly, given the sharp rally in the market and the late-in-the-month positive sentiment towards Europe the Puts/Hedges (-56bps), and the Currencies (-32bps) books were the main negative contributors.  The China Thesis (-39bps) also hurt performance, with hopes of a soft landing in China and the potential for recovery in Europe (China’s largest export market) working against the book.

Against this, the equity-centric books were the positive driver’s of performance.  The Value Equities (+61bps) book was aided by the constructive market environment, with THRX benefiting from the positive sentiment in the biotech/healthcare space which saw a number of transactions, including GlaxoSmithKline’s completion of its acquisition of 10mn shares in THRX that was announced in April.  The Energy Efficiency book (+77bps) was the largest contributor to the portfolio.  The book was driven by the performance in XIDE, which announced reasonable numbers.  The company has a checkered history with constant Given the company’s terrible history of restructuring and constant charges the company rightly trades at a discount to peers; however, the hints that the current management are reaching the end of their restructuring after bringing the company out of bankruptcy could have a substantial impact on the firm’s Earnings, ability to capture some of the market (in micro-hybrids) that’s becoming available to them, and their rating.  We shall see, over the next couple of years, if it’s another false dawn in Exide’s emergence.

Elsewhere the Treasuries (-8bps), Bond Funds (+4bps) and NCAV (+1bp) books had a very limited impact on performance.

Portfolio (as at 6/30 - all delta and leverage adjusted, as appropriate)
18.9% - Bond/Absolute Return Funds (DLTNX and HSTRX)
6.5% - Value Idea Equities (THRX, and DRWI)
5.1% - Treasury Bonds (TLT)
2.8% - Energy Efficiency (AXPW, and XIDE)
0.5% - NCAV Equities
0.0% - Other Equities (none)

-1.9% - China-Related Thesis (60bps premium in EWZ Jan-13 puts)
-0.5% - Hedges/Put Options (19bps in IWM Jan-13 puts, 17bps in SPY Jan-13 puts and 12bps XLY Jan-13 puts)

-12.4% - Currencies (EUO – Short Euro)

59.0% - Cash 

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.


Thursday, June 28

It's Okay to Not Know...


“[T]here are known knowns; there are things we know that we know.
There are known unknowns; that is to say there are things that, we now know we don't know.
But there are also unknown unknowns – there are things we do not know, we don't know. ”
— US Secretary of Defense, Donald Rumsfeld

While I was never much of a fan of Secretary Rumsfeld, it always struck me as peculiar the people took such issue with this statement as it seems a fairly logical distillation of a rather complex thing.  Given that a number of Our Man's friends, acquaintances and contacts are in the financial world, it's even stranger that folks criticized the statement as it would seem to me that unknown unknowns could just as easily be called Black Swans.  Though, I suppose it was made in a pre-2008 world when black swans weren't as popular a topic.

So, why bring up Secretary Rumsfeld’s quote now?  Well, despite what you might hear if you have the misfortune to tune into CNBC, it’s okay to not know or have any conviction in a particular outcome.  It is however, important that you realize that you have limited conviction and behave accordingly.  We’re taught that if we do the “work” – if we research, think about and analyze a problem – we’ll find the answer (i.e. reach a conclusion in which we have conviction).  It’s those known unknowns and the pesky Black Swans (unknown unknowns) that mean this isn’t the case in reality.

I bring this up because Our Man’s portfolio continues to run relatively low exposure and the performance is where it has been all year, roughly flat.  The low exposure is a reflection of my lack of conviction; that I don’t know.  On the Equity-side, this is easy to explain – while the current positions have sufficient assets or earnings to make them ‘cheap’, most of the driver of future returns is based upon some form of change or future growth.  While I believe that you’re paying little to nothing for this growth and/or I’m more positive on the probability of its occurrence, potential size, and proximity, it’s also very likely given their uncertain nature that these factors will be influenced by the macro environment.  Thus, the positions are undersized to reflect my well-known macro skepticism.  What will cause the equity book to grow?  Well, a change in the macro conditions, a change in the risk/reward in existing names, or adding new names or a theme to the book; expect to hear more on these topics soon.

So, if I’m bearish, why are the Puts/Hedges and China thesis portfolios so small?  Well, for the following reasons: we’re not there yet and the Fed (and other Central Banks).  While my bearishness is unchanged and the economy remains relatively weak (and I think noticeably weaker than people realize) it isn’t yet absolutely weak.  As discussed before, my two favourite indicators for getting a sense of where the economy stands today are the Philly Fed’s Aruoba-Diebold-Scotti Business Conditions Index and the Chicago Fed National Activity Index. 





The second reason is the Fed who have shown a belief that throwing liquidity at problems will solve them, despite the lack of evidence that it does any more than provide a temporary sugar high while potentially creating greater distortions in the markets.  However, their willingness to do so seemingly every year (surely a sign of its outstanding success) means that there is a higher bar required (i.e. the economy must be weaker than historically) or signs of greater exogenous weakness (China and Europe) before I’m willing to increase the size.  

In short, my current level of conviction is relatively low ("I don't know") and thus the portfolio's level of exposure is low. So I'm spending my time doing two things (i) waiting for the data to change and help me build some short-medium term conviction in the existing theses, and (ii) looking into, researching, thinking about and analyzing some new ones.  When I've either built greater conviction in the existing theses or am close to putting new ones into the book, then this blog will become more lively and the portfolio's exposure and risk will start to increase.

Sunday, June 10

Things from my Google Reader: Jun-12 Edition


Apparently, it has been almost 9 months since Our Man updated you with articles of interest that he’s been reading.  Thankfully, this isn’t a reflection of a drop in the quality of his reading material but instead solely represents at how poor he’s been posting it to this blog – apparently, putting the information together in a word document and expecting it to post itself, doesn’t work so well.  Thus, there is much catching up to do…so expect a plethora of “Things from my Google Reader” posts this summer.  This one will follow the typical format, with the most financial-orientated links at the bottom!

As you know, Our Man is a Brit and there’s nothing Brits like more than a cup of char (in fact, I’m having one now…as I write this).  I also have to say that American tea-making standards are pretty low (Mrs. OM is a fan of putting the milk in first, perish the thought!).  So, in this stressful world (and especially for my American friends) let George Orwell’s 1946 article school you on this important matter.  (George Orwell, Evening Standard)

I’m sure you’ve all seen the slogan on t-shirts and posters, but have you ever wondered where it came from?   This short film tells you the story behind the poster; from its origins at the start of the second World War, to how it was rediscovered in an English bookshop in 2000 and introduced into the public consciousness.

Given that top class athletes and singers have coaches, so why don’t you have one for whatever you do?  Irrespective of your training for your job, can you perform at your best on your own?  Clearly, some occupations lend themselves to this concept better than others but it’s a fascinating concept and well worth you reading about one surgeon’s experiences and research.  (Atul Gawande, New Yorker)

All things China
As y’all know, Our Man has been somewhat skeptical on China for a long-time.  While this was originally a contrarian view, the debate over China has progressed from whether China will (ever) slow-down to whether there will be a soft or hard landing and what’s a reasonable rate of growth to expect from China going forwards.  Here are some interesting articles that illustrate the change in tone over China, from the last few months:
- Professor Michael Pettis and the Economist’s Free Exchange blog have a two-legged wager on whether China will overtake the US within a decade and what Chinese GDP growth will be. (Michael Pettis’ blog & The Economist)
- Jonathan Weil finds that Chinese big banks look more like paper tigers, in large part to the remnants of the last time the government had to bail them out (something Our Man has discussed before). (Jonathan Weil, Bloomberg)
- Arthur Kroeber wonders if it will be social discontent and income inequality that will lead to China having issues (Arthur Kroeber, Foreign Policy)
- John Hempton is the most skeptical of all, suggesting China’s a “kleptocracy of a scale never seen before in human history” and tries to explain how it’s financed, and what might make it fail.  (John Hempton, Bronte Capital)

Financial Regulation – Some Andy Haldane love!
Financial regulators have done little good over recent decades, in large part because they’ve failed to understand Finance.   One of the few exceptions is Andy Haldane, the FSA’s Executive Director for Financial Stability, who Justin Fox (at HarvardBusiness Review) dubbed “the regulator who explained the world”. 
Personally, I was more impressed by the way the way he applied work from other fields and considered their impacts on finance.  Some of my favourite Haldane articles/speeches:
- “Patience & Finance”, where he looks at the role of patience in decision-making and the impact of patience, or rather succumbing to impatience has had, on finance.  (Oxford China Business Forum, in Beijing) 
- “The Short Long”, on whether the world (and stock market in particular) is becoming more short-sighted and myopic.
- “The Doom Loop”, where he talks about equity and the banking system. (Andy Haldane, London Review of Books)

Sunday, June 3

May 2012 Review


Portfolio Update 
There were no changes to the portfolio during May. 

Performance Review
In similar fashion to both 2010 and 2011 the old stock market adage “Sell in May and go away”, proved to be useful advice as the S&P 500 tumbled by over 6%.  Unsurprisingly, it was as macro fears across the globe raised their heads once more.  In Europe, the slow-moving car crash continued as Greece’s elections brought matters to a head, with the possibility of Greece’s exit (which seems to have been term a “Grexit”) being openly discussed for the first time, while Spain seems to be doing its best to follow Ireland’s version of the bank & real estate debt problems!  The news outside of Europe wasn’t much better as speculation and debate continues as to whether China will have a hard landing or will instead avoid it through another large stimulus program in the full knowledge that the 2009-stimulus program only made their long-term economic rebalancing much harder.  Not to be left out, the US showed continued signs of softening in the economy, though it’s yet to reach levels where the talking heads are speculating about recession.  

Given the portfolio’s slightly negative/bearish tilt it fared reasonably well during May rising 1.13%, though it still remains underwater for the year (-9bps YTD).  The breakdown of performance was unsurprising.  The China book (+47bps) and Puts/Hedges (+42bps) both benefited as equity markets fell, with the Treasury book (+39bps) benefiting from the flight to quality.  The largest contributor was the Currencies book (+77bps) which benefited from the USD strengthening against the Euro following uncertainty in Europe, especially the fears that Greece would exit the Euro and speculation this could lead to contagion across Europe.

Equally unsurprising was that the equity-orientated books suffered heavily during the month, with both the Value Equities (-61bps) and Energy Efficiency (-46bps) books hampering performance.  As regular readers know, the names in these books tend to be smaller-capitalization companies where either a large part of their value is in (expected) future growth (i.e. the Energy Efficiency book) or where there is some uncertainty be it over legal issues, the value of an asset, the company’s normalized earnings, or corporate behavior/action.  Unfortunately, these traits mean that if there is no idiosyncratic even affecting the names in these books, they can be sold off heavily during bouts of uncertainty.  The Bond/Absolute Return Funds (+2bps) and NCAV (+12bps) books weren’t significant contributors to performance.

Portfolio (as at 5/31 - all delta and leverage adjusted, as appropriate)
17.6% - Bond/Absolute Return Funds (DLTNX and HSTRX)
5.5% - Value Idea Equities (THRX, and DRWI)
4.8% - Treasury Bonds (TLT)
1.9% - Energy Efficiency (AXPW, and XIDE)
0.5% - NCAV Equities
0.0% - Other Equities (none)

-2.4% - China-Related Thesis (92bps premium in EWZ Jan-13 puts)
-2.8% - Hedges/Put Options (37bps in IWM Jan-13 puts, 36bps in SPY Jan-13 puts and 25bps XLY Jan-13 puts)

-12.1% - Currencies (EUO – Short Euro)

61.8% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.

Sunday, May 6

April 2012 Review


Portfolio Update 
April saw some changes to the portfolio:
- Portfolio Redemption:  April is tax season in the US (and home improvement season in Mrs OM's mind!) and with this in mind Our Man and Mrs. OM decided earlier in the year to reduce their allocation to the portfolio at the end of Q1.  Given the large amount of cash in the portfolio and Our Man’s conviction in his names/theses, rather than selling positions to match the outflow, Our Man has reduced his cash position.  This has the impact of increasing the exposure to existing positions by c10%.
- NCAV Book changes:  As mentioned in the most recent NCAV post a number of positions within the NCAV bucket reached their sell-by date (see here for sell rules).  These positions were sold during April, leaving the NCAV portfolio with a solitary position.

Performance Review
April proved to be the portfolio’s first profitable month (+64bps) of the year though the portfolio is still negative for the year (-1.2% YTD).  While April saw the return of some uncertainty to the markets, which fell slightly over the course of the month, the portfolio’s profits were surprisingly broadly spread.

A number of books posted marginal gains/losses, which largely cancelled each other out.  The NCAV book (-4bps) was down for the month, though this largely represented the costs (mainly brokerage commissions) of exiting the majority of the portfolio.  The Currencies book (+7bps) benefited from the uncertainty in Europe and the China book (+2bps) from the mixed signals on Chinese growth.  The Puts/Hedges book (-5bps) was a mild detractor despite the small fall in equity markets

The Treasury Book (+21bps) and the Bond/Absolute Return Funds (+19bps) were both aided by the strengthening of US Treasuries over the course of the month, as uncertainty (especially over Europe) increased.  This uncertainty negatively impacted the Energy Efficiency book (-15bps) to a relatively large degree, given the speculative nature of one of the names (AXPW) and the mediocre recent history of another (XIDE).

The Value Equity book (+40bps), which has largely been disappointing to date, bucked the trend and had a strong month despite the small fall in the equity markets.  The performance was driven by the position in THRX, which rose after announcing that GlaxoSmithKline, its joint venture partner, was further increasing its stake in the business at a price above the then market value


Portfolio (as at 3/31 - all delta and leverage adjusted, as appropriate)
17.7% - Bond/Absolute Return Funds (DLTNX and HSTRX)
6.1% - Value Idea Equities (THRX, and DRWI)
4.5% - Treasury Bonds (TLT)
2.3% - Energy Efficiency (AXPW, and XIDE)
0.4% - NCAV Equities
0.0% - Other Equities (none)

-1.5% - China-Related Thesis (46bps premium in EWZ Jan-13 puts)
-2.4% - Hedges/Put Options (24bps in IWM Jan-13 puts, 20bps in SPY Jan-13 puts and 13bps XLY Jan-13 puts)

-10.7% - Currencies (EUO – Short Euro)

62.5% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.